Ocugen, Inc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. 

CEO
Shankar Musunuri
CEOShankar Musunuri
Employees
95
Employees95
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2013
Founded2013
Employees
95
Employees95

OCGN Key Statistics

Market cap
315.39M
Market cap315.39M
Price-Earnings ratio
-5.83
Price-Earnings ratio-5.83
Dividend yield
Dividend yield
Average volume
6.22M
Average volume6.22M
High today
$1.24
High today$1.24
Low today
$1.05
Low today$1.05
Open price
$1.12
Open price$1.12
Volume
10.15M
Volume10.15M
52 Week high
$1.98
52 Week high$1.98
52 Week low
$0.515
52 Week low$0.515

People also own

Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.